OptimizeRx (OPRX) Balance Sheet: Assets & Liabilities

OptimizeRx (OPRX) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), OptimizeRx reported total assets of $176.92M and total liabilities of $48.62M. Shareholders' equity was $128.29M, up 9.7% from $117.00M a year earlier. Total debt stood at $25.68M against $23.36M in cash and short-term investments, a net debt position of $2.31M. That puts debt-to-equity at 0.20, compared with 0.28 a year earlier.

OptimizeRx Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for OptimizeRx Corporation (OPRX) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Mar 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	23.37	13.38	13.85	13.85	18.21	84.68	10.52	18.85	8.91	5.12
Short-Term Investments	0.00	0.00	0.00	-	55.93	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	23.37	13.38	13.85	13.85	74.14	84.68	10.52	18.85	8.91	5.12
Accounts Receivable	37.75	38.21	37.29	36.25	22.16	24.80	17.89	7.42	6.46	3.43
Inventory	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.51	2.38	3.19	0.41	2.28	0.61	4.46	0.87	0.59	0.26
Total Current Assets	64.72	53.97	54.33	54.33	98.58	115.11	32.86	27.14	15.96	8.81
Non-Current Assets
Property, Plant & Equipment (Net)	0.51	0.52	0.72	0.72	0.37	0.47	0.59	0.74	0.15	0.17
Goodwill	70.87	70.87	78.36	78.36	22.67	14.74	14.74	14.74	3.68	0.00
Intangible Assets	40.80	45.52	49.40	49.40	13.02	10.65	12.12	13.94	5.26	0.78
Other Non-Current Assets	0.03	0.30	0.57	0.57	0.01	0.01	0.01	0.08	0.01	0.01
Total Non-Current Assets	112.20	117.20	129.04	129.04	36.07	25.87	27.47	29.50	9.09	0.95
Total Assets	176.92	171.17	183.37	183.37	134.65	140.99	60.33	56.64	25.05	9.76
Current Liabilities
Accounts Payable	1.64	2.16	2.23	2.23	1.55	0.61	0.62	0.49	0.41	0.46
Short-Term Debt	4.26	2.17	2.22	2.00	0.09	0.09	0.12	0.12	0.00	0.00
Current Portion of Long-Term Debt	4.26	2.00	-	2.00	-	-	-	-	-	-
Accrued Liabilities	11.59	8.49	-	7.71	2.60	2.90	2.42	-	-	-
Deferred Revenue	0.50	0.47	0.17	0.17	0.16	1.39	0.29	0.58	0.61	0.51
Other Current Liabilities	3.09	13.54	13.21	5.56	6.59	4.38	9.00	4.92	3.21	2.58
Total Current Liabilities	21.26	18.65	17.88	17.88	8.40	9.37	10.03	6.11	4.23	3.54
Non-Current Liabilities
Long-Term Debt	21.42	31.03	34.60	34.23	0.14	0.24	0.33	0.45	0.00	0.00
Deferred Tax Liabilities	5.71	4.49	4.34	4.34	0.00	0.00	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	5.71	0.00	0.00	4.34	0.00	0.00	0.00	5.22	2.37	0.00
Total Non-Current Liabilities	27.36	35.52	38.94	38.94	0.14	0.24	0.33	5.67	2.37	2.58
Total Liabilities	48.62	54.17	56.82	56.82	8.54	9.61	10.35	11.78	6.60	3.54
Stockholders' Equity
Common Stock	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.01	0.01	0.03
Retained Earnings	-79.24	-84.37	-64.26	-64.26	-46.69	-35.25	-35.63	-33.42	-30.28	-30.36
Accumulated Other Comprehensive Income	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00	-0.10	-0.07
Treasury Stock	0.00	0.00	-	0.00	0.00	-	-	-	-	-
Additional Paid-in Capital	207.51	201.35	190.79	190.79	172.78	166.62	85.59	78.27	48.73	35.27
Shares Outstanding	18.76	18.45	-	18.16	17.07	17.86	-	-	-	-
Total Stockholders' Equity	128.29	117.00	126.55	126.55	126.11	131.38	49.97	44.86	18.46	6.22
Total Liabilities & Equity	176.92	171.17	183.37	183.37	134.65	140.99	60.33	56.64	25.05	9.76

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About OptimizeRx Balance Sheet

How much debt does OptimizeRx have?

OptimizeRx had total debt of $25.68M as of Dec 31, 2025, against $23.36M in cash and short-term investments. Its debt-to-equity ratio was 0.20. Total debt was $33.19M a year earlier.

What are OptimizeRx's total assets?

OptimizeRx reported total assets of $176.92M as of Dec 31, 2025, up 3.4% from $171.17M a year earlier. Total liabilities were $48.62M.

What is OptimizeRx's shareholders' equity?

OptimizeRx's shareholders' equity was $128.29M as of Dec 31, 2025, or about $6.84 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition